Clincosm LogoSign in Get a demo

Shanghai Epidemiology Study for Adolescents and Children With Cancer

Sponsor
Children's Cancer Group, China (Other)
Overall Status
Recruiting
CT.gov ID
NCT02959086
Collaborator
Shanghai Children's Medical Center (Other), Shanghai Municipal Center for Disease Prevention & Control (Other)
2,000
Enrollment
2
Locations
336
Anticipated Duration (Months)
1000
Patients Per Site
3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to describe the morbidity, mortality, disability and survival rate in Shanghai adolescents and children with cancer diagnosed since January 2002.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The investigators collected information of all the adolescents and children diagnosed cancer in Shanghai since January 2002, including their name, gender, the date of birth, the diagnosis date, disease diagnosis, residence address and the last follow-up time status (survival/death). The type of cancer included all malignant tumors such as Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, central nervous system tumors, Neuroblastoma, Wilms tumor and so on. Then the investigators would analyze the morbidity, mortality, disability and survival rate.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    2000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Shanghai Epidemiology Study for Adolescents and Children With Cancer
    Actual Study Start Date :
    Jan 1, 2002
    Actual Primary Completion Date :
    Apr 1, 2017
    Anticipated Study Completion Date :
    Jan 1, 2030

    Arms and Interventions

    Arm Intervention/Treatment
    1

    Patients were diagnosed since January 2002.

    Outcome Measures

    Primary Outcome Measures

    1. Overall survival for the whole cohort [5 years]

    Secondary Outcome Measures

    1. Mortality for the whole cohort [5 years]

    Other Outcome Measures

    1. Disability rate for the whole cohort [5 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    0 Years to 19 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • 0-19 year-old children and adolescents.

    • Diagnosed cancer in Shanghai since January 2002.

    Exclusion Criteria:

    • Patients who were lost of follow-up.

    • Patient's death wasn't caused by cancer or complications but by other accidents such as car accident, fell from a great height and so on.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Shanghai Children's Medical Center Shanghai Shanghai China 200127
    2 Shanghai Municipal Center of Disease Prevention & Control Shanghai Shanghai China 200336

    Sponsors and Collaborators

    • Children's Cancer Group, China
    • Shanghai Children's Medical Center
    • Shanghai Municipal Center for Disease Prevention & Control

    Investigators

    • Principal Investigator: Yi-Jin Gao, MD, Shanghai Children's Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Children's Cancer Group, China
    ClinicalTrials.gov Identifier:
    NCT02959086
    Other Study ID Numbers:
    • CCGChina
    First Posted:
    Nov 8, 2016
    Last Update Posted:
    Jul 30, 2021
    Last Verified:
    Jul 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Children's Cancer Group, China
    Epidemiology
    Shanghai
    Cancer
    Adolescents
    Children

    Study Results

    No Results Posted as of Jul 30, 2021